The platelet count in Chronic Myeloid Leukemia (CML) varies depending on the phase of the disease. While it can be elevated in the chronic phase, it tends to decrease in the accelerated or blast phase.
In the transitional or accelerated phase of CML, a reduction in platelet counts to less than 100,000 cells/μL unrelated to therapy is a characteristic finding.
Therefore, the answer depends on the specific phase of CML. While elevated in the chronic phase, a platelet count of less than 100,000 cells/μL suggests progression to accelerated phase.
